Effect of CYP1A1 MSPI Polymorphism on the Relationship Between TP53 Mutation and CDKN2A Hypermethylation in Non-small Cell Lung Cancer (Q82874963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

title

Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

Effect of CYP1A1 MSPI Polymorphism on the Relationship Between TP53 Mutation and CDKN2A Hypermethylation in Non-small Cell Lung Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

19 December 2024

1 reference

non-small-cell lung carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22154617

19 December 2024

genetic polymorphism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22154617

19 December 2024

author name string

Cong Tan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

He-Yun Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

Chen-Ye Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

Hu Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

Chun-Mei Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

Wei-Min Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

Xiao-Yu Sun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

Yong-Tang Jin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22154617

19 December 2024

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

7 December 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22154617

full work available at URL

19 December 2024

https://api.elsevier.com/content/article/PII:S0188440911002554?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

https://api.elsevier.com/content/article/PII:S0188440911002554?httpAccept=text/plain

19 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Archives of Medical Research

19 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

669-676

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

Epidemiology of Lung Cancer

18 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis

19 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Lung cancer epigenetics and genetics

19 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer

19 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Glutathione S-transferase mu1 null genotype is associated with K-ras gene mutation in lung adenocarcinoma among smokers

19 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes

19 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm.

19 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53

19 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

19 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

19 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.

19 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.

19 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma

19 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

p53-mediated repression of DNA methyltransferase 1 expression by specific DNA binding

19 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer

19 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

p16INK4a modulates p53 in primary human mammary epithelial cells.

19 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Combined effects of serum trace metals and polymorphisms of CYP1A1 or GSTM1 on non-small cell lung cancer: a hospital based case-control study in China

19 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China

19 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers

19 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers

19 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Mutational and Epigenetic Evidence for Independent Pathways for Lung Adenocarcinomas Arising in Smokers and Never Smokers

19 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer

19 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer

19 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.

19 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors

19 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer

19 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer.

19 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications.

19 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Dose effect of smoking on aberrant methylation in non-small cell lung cancers

19 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity

19 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers

19 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

p53 Deficiency leads to compensatory up-regulation of p16INK4a

19 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Real-time in vivo imaging of p16Ink4a reveals cross talk with p53.

19 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice

19 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

Glutathione conjugation as a bioactivation reaction

19 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.ARCMED.2011.11.008

19 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22154617 AND SRC:MED&resulttype=core&format=json

18 January 2020

1 reference